Literature DB >> 16956601

Molecular mechanisms of insulin resistance and associated diseases.

Barbara Mlinar1, Janja Marc, Andrej Janez, Marija Pfeifer.   

Abstract

Insulin resistance is a state in which higher than normal concentrations of insulin are required for normal response. The most common underlying cause is central obesity, although primary insulin resistance in normal-weight individuals is also possible. Excess abdominal adipose tissue has been shown to release increased amounts of free fatty acids which directly affect insulin signalling, diminish glucose uptake in muscle, drive exaggerated triglyceride synthesis and induce gluconeogenesis in the liver. Other factors presumed to play the role in insulin resistance are tumour necrosis factor alpha, adiponectin, leptin, IL-6 and some other adipokines. Hyperinsulinaemia which accompanies insulin resistance may be implicated in the development of many pathological states, such as hypertension and hyperandrogenaemia. Insulin resistance underlies metabolic syndrome and is further associated with polycystic ovary syndrome and lipodystrophies. When beta-cells fail to secrete the excess insulin needed, diabetes mellitus type 2 emerges, which is, besides coronary heart disease, the main complication of insulin resistance and associated diseases.

Entities:  

Mesh:

Year:  2006        PMID: 16956601     DOI: 10.1016/j.cca.2006.07.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  62 in total

1.  Congenital and environmental factors associated with adipocyte dysregulation as defects of insulin resistance.

Authors:  Chao-Ping Wang; Fu-Mei Chung; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2007-08-10

2.  Dietary cocoa reduces metabolic endotoxemia and adipose tissue inflammation in high-fat fed mice.

Authors:  Yeyi Gu; Shan Yu; Jong Yung Park; Kevin Harvatine; Joshua D Lambert
Journal:  J Nutr Biochem       Date:  2013-12-31       Impact factor: 6.048

Review 3.  MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.

Authors:  Basak Icli; Mark W Feinberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

4.  ABO blood type, diabetes and risk of gastrointestinal cancer in northern China.

Authors:  Yan Gong; Yun-Sheng Yang; Xiao-Mei Zhang; Ming Su; Jean Wang; Jin-Dong Han; Ming-Zhou Guo
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

5.  Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice.

Authors:  Sanjaya K Satapathy; Mahendar Ochani; Meghan Dancho; Laqueta K Hudson; Mauricio Rosas-Ballina; Sergio I Valdes-Ferrer; Peder S Olofsson; Yael Tobi Harris; Jesse Roth; Sangeeta Chavan; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2011-07-01       Impact factor: 6.354

Review 6.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  Dietary cocoa ameliorates obesity-related inflammation in high fat-fed mice.

Authors:  Yeyi Gu; Shan Yu; Joshua D Lambert
Journal:  Eur J Nutr       Date:  2013-03-15       Impact factor: 5.614

8.  Sustained βAR Stimulation Mediates Cardiac Insulin Resistance in a PKA-Dependent Manner.

Authors:  Supachoke Mangmool; Tananat Denkaew; Sarawuth Phosri; Darawan Pinthong; Warisara Parichatikanond; Tsukasa Shimauchi; Motohiro Nishida
Journal:  Mol Endocrinol       Date:  2015-12-11

9.  Cross-sectional association of dietary patterns with insulin-resistant phenotypes among adults without diabetes in the Framingham Offspring Study.

Authors:  Enju Liu; Nicola M McKeown; P K Newby; James B Meigs; Ramachandran S Vasan; Paula A Quatromoni; Ralph B D'Agostino; Paul F Jacques
Journal:  Br J Nutr       Date:  2009-02-16       Impact factor: 3.718

Review 10.  Potential roles of fibroblast growth factor 21 in the brain.

Authors:  Piangkwan Sa-Nguanmoo; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2016-01-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.